IMM 1.64% 30.0¢ immutep limited

Ann: Immutep Reveals a New anti-LAG-3 Research Program, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 577 Posts.
    lightbulb Created with Sketch. 65
    pretty exciting stuff.. easily distributed long shelf life pharmacy held wide use profile

    plays into treatment in autoimmune conditions as a monotherapy..

    check the list if you have not already....
    https://www.aarda.org/diseaselist/
    plenty of costly illnesses to society... as well as early cancer treatment without the need for chemo therapeutics.
    if they can do it with imp321, they can do it with the whole product pipeline...

    check out Freddy T's interview... https://www.immutep.com/investors-media/press-releases-72.html April 2021.

    the biggest discovery for a soon to be widely used medication since paracetamol....https://en.wikipedia.org/wiki/Paracetamol
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.005(1.64%)
Mkt cap ! $436.3M
Open High Low Value Volume
30.5¢ 31.3¢ 30.0¢ $960.6K 3.161M

Buyers (Bids)

No. Vol. Price($)
14 188729 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 46153 2
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.